{"id":15782,"date":"2024-12-12T17:42:17","date_gmt":"2024-12-12T22:42:17","guid":{"rendered":"https:\/\/fibrocanada.ca\/?p=15782"},"modified":"2026-04-09T09:14:49","modified_gmt":"2026-04-09T13:14:49","slug":"university-of-calgary-fibromyalgia-study","status":"publish","type":"post","link":"https:\/\/www.fibrocanada.ca\/fr\/university-of-calgary-fibromyalgia-study","title":{"rendered":"Universit\u00e9 de Calgary \u2013 iTBS \u2013 \u00c9tude sur le DCS dans la fibromyalgie"},"content":{"rendered":"\n

<\/p>\n\n\n\n\n\n

Fibromyalgia Study at U of C in Calgary, AB.<\/h2>\n\n\n\n

The University of Calgary is conducting an ongoing fibromyalgia study into the effectiveness of transcranial magnetic stimulation (TMS), coupled with a medication called D-cycloserine in a double blind study as a treatment for fibromyalgia pain and many of the co-morbid symptoms such as depression and anxiety. The study involves the application of a protocol called intermittent theta-burst stimulation (iTBS) to a targeted spot in the dorsolateral prefrontal cortex of the brain. The study is being conducted by the team at Mathison Centre for Mental Health Research & Education by Dr. Alexander McGirr and team.<\/p>\n\n\n\n

\n

<\/p>\n\n\n\n

This study is being conducted in Calgary, Alberta and requires several in-person visits over a four week period to the clinic to receive the onboarding, treatment and follow up sessions.<\/p>\n\n\n\n

<\/p>\n<\/blockquote>\n\n\n\n

They are currently seeking participants in the Calgary area between the ages of 18-65. For further information, please visit clinicaltrials.gov<\/a> or contact neurostim@ucalgary.ca to discuss details with one of their research coordinators.<\/p>\n\n\n\n

<\/p>\n\n\n\n

\"\"<\/figure>\n\n\n\n

To find out about other research and fibromyalgia studies, visit our Current Research<\/a> page to find out more.<\/p>\n\n\n

[\/trp_language]<\/p>\n\n\n<\/p>\n\n\n\n

L\u2019Universit\u00e9 de Calgary m\u00e8ne actuellement une \u00e9tude sur la fibromyalgie afin de d\u00e9terminer l\u2019efficacit\u00e9 de la stimulation magn\u00e9tique transcr\u00e2nienne (TMS), associ\u00e9e \u00e0 un m\u00e9dicament appel\u00e9 D-cyclos\u00e9rine, dans le cadre d\u2019une \u00e9tude en double aveugle pour traiter la douleur li\u00e9e \u00e0 la fibromyalgie et de nombreux sympt\u00f4mes comorbides tels que la d\u00e9pression et l\u2019anxi\u00e9t\u00e9. L\u2019\u00e9tude consiste \u00e0 appliquer un protocole appel\u00e9 stimulation par impulsions th\u00eata intermittentes (iTBS) \u00e0 un point cibl\u00e9 du cortex pr\u00e9frontal dorsolat\u00e9ral du cerveau. L\u2019\u00e9tude est men\u00e9e par l\u2019\u00e9quipe du Centre Mathison pour la recherche et l\u2019\u00e9ducation en sant\u00e9 mentale, dirig\u00e9e par le Dr Alexander McGirr et son \u00e9quipe.<\/p>\n\n\n\n

\n

<\/p>\n\n\n\n

Cette \u00e9tude est men\u00e9e \u00e0 Calgary, en Alberta, et n\u00e9cessite plusieurs visites en personne sur une p\u00e9riode de quatre semaines \u00e0 la clinique pour recevoir les s\u00e9ances d'int\u00e9gration, de traitement et de suivi.<\/p>\n\n\n\n

<\/p>\n<\/blockquote>\n\n\n\n

Ils recherchent actuellement des participants dans la r\u00e9gion de Calgary \u00e2g\u00e9s de 18 \u00e0 65 ans. Pour plus d'informations, veuillez consulter clinicaltrials.gov<\/a> ou contactez neurostim@ucalgary.ca pour discuter des d\u00e9tails avec l'un de leurs coordonnateurs de recherche. Cette \u00e9tude est men\u00e9e en anglais.<\/p>\n\n\n\n

\"\"<\/figure>\n\n\n\n

Pour en savoir plus sur d\u2019autres recherches et \u00e9tudes sur la fibromyalgie, visitez notre page Recherche actuelle<\/a> pour en savoir plus.<\/p>\n\n\n\n

<\/div>\n\n\n

\n\n\n\n

<\/p>\n\n\n\n

<\/p>\n","protected":false},"excerpt":{"rendered":"

L\u2019Universit\u00e9 de Calgary m\u00e8ne une \u00e9tude continue sur la fibromyalgie pour rechercher l\u2019utilisation de la TMS et d\u2019un m\u00e9dicament pour le traitement de la douleur li\u00e9e \u00e0 la fibromyalgie et des comorbidit\u00e9s associ\u00e9es.<\/p>","protected":false},"author":4,"featured_media":15868,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","footnotes":""},"categories":[51],"tags":[],"class_list":["post-15782","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-past","pmpro-has-access"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.fibrocanada.ca\/fr\/wp-json\/wp\/v2\/posts\/15782","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fibrocanada.ca\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fibrocanada.ca\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fibrocanada.ca\/fr\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fibrocanada.ca\/fr\/wp-json\/wp\/v2\/comments?post=15782"}],"version-history":[{"count":1,"href":"https:\/\/www.fibrocanada.ca\/fr\/wp-json\/wp\/v2\/posts\/15782\/revisions"}],"predecessor-version":[{"id":23777,"href":"https:\/\/www.fibrocanada.ca\/fr\/wp-json\/wp\/v2\/posts\/15782\/revisions\/23777"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fibrocanada.ca\/fr\/wp-json\/wp\/v2\/media\/15868"}],"wp:attachment":[{"href":"https:\/\/www.fibrocanada.ca\/fr\/wp-json\/wp\/v2\/media?parent=15782"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fibrocanada.ca\/fr\/wp-json\/wp\/v2\/categories?post=15782"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fibrocanada.ca\/fr\/wp-json\/wp\/v2\/tags?post=15782"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}